Our Story

A Legacy of Scientific Excellence

Founded in 2001 in Washington, D.C., Altriva Pharmaceuticals began with a simple but powerful vision: to make high-quality medicines accessible to every patient who needs them. What started as a small research team of 15 scientists has grown into a global pharmaceutical enterprise employing over 4,000 professionals.

Over the past 25 years, Altriva has built a reputation for scientific rigor, manufacturing excellence, and unwavering ethical standards. Our FDA-approved facilities span three states, and our products are trusted by healthcare providers in more than 30 countries.

Today, Altriva stands at the intersection of scientific innovation and compassionate care — developing treatments that not only extend life but improve its quality.

Our Foundation

Mission & Values

Our Mission

To advance human health by developing and delivering innovative, high-quality pharmaceutical solutions that improve patient outcomes and enhance quality of life worldwide.

Innovation

We invest heavily in R&D to discover breakthrough therapies that address unmet medical needs, pushing the boundaries of what is possible in medicine.

Integrity

We conduct business with the highest ethical standards, ensuring regulatory compliance, transparent practices, and accountability at every level.

Accessibility

We believe everyone deserves access to quality medicine. Our global distribution network and patient assistance programs make treatment available to underserved communities.

Leadership

Executive Team

Our leadership brings decades of pharmaceutical, scientific, and business expertise.

Dr. Michael Torres

Chief Executive Officer

30+ years of pharmaceutical leadership. Former SVP at Pfizer and Merck. PhD in Pharmacology from Johns Hopkins.

Dr. Amara Okafor

Chief Scientific Officer

Leading Altriva's R&D strategy. Previously held leadership roles at Novartis and Genentech. MD, PhD from Stanford.

Robert Chen

Chief Operating Officer

Oversees global manufacturing and supply chain. 25 years in operations management at Johnson & Johnson and Baxter.

Sarah Williams

Chief Compliance Officer

Ensures regulatory excellence across all operations. Former FDA official with deep expertise in pharmaceutical compliance.